Home/Investors/National Institutes of Health (NIH)

National Institutes of Health (NIH)

Biotech Investor · 42 portfolio companies

Portfolio
42
Focus Areas
60
Top Stage
Pre-clinical

Portfolio Companies

CompanyValuation
Astrocyte Pharmaceuticals
CinderBio
Chrysalis BioTherapeutics
Clear Guide Medical
Collaborations Pharmaceuticals
MassMatrix
BioSignal Group
Globin Solutions
Proteovista
Ionic Pharmaceuticals
Longevity Biotech
Intezyne
Annoviant
AyuVis Research
Kovina Therapeutics
Plakous Therapeutics
Dynocardia
RevBio
TissueVision
Plurexa
Instanosis
Xona Microfluidics
Claremont BioSolutions
Advanced Brain Monitoring
Koliber Biosciences
7 Hills Pharma
Aurora Oncology
Trethera
TSRL Inc
RealSeq Biosciences
Rebel Medicine
Aquilus Pharmaceuticals
Fzata
NanoEngineering Corp.
NextStep Robotics
Orlance
AcousticaBio
Vona Oncology
Regenovva
StemCellerant
Peroxitech
Sparian Biosciences